XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Effect of Net Investment Hedges on OCI and the Consolidated Statement of Income
The effects of the Company’s net investment hedges on OCI and the Consolidated Statement of Income are shown below:
Amount of Pretax (Gain) Loss Recognized in Other Comprehensive Income (1)
Amount of Pretax (Gain) Loss Recognized in Other (income) expense, net for Amounts Excluded from Effectiveness Testing
Three Months Ended March 31,Three Months Ended March 31,
($ in millions)2022202120222021
Net Investment Hedging Relationships
Foreign exchange contracts
$(16)$(25)$(1)$(4)
Euro-denominated notes(53)(166)— — 
(1) No amounts were reclassified from AOCL into income related to the sale of a subsidiary.
Summary of Interest Rate Swaps Held At March 31, 2022, the Company was a party to four pay-floating, receive-fixed interest rate swap contracts designated as fair value hedges of fixed-rate notes in which the notional amounts match the amount of the hedged fixed-rate notes as detailed in the table below.
March 31, 2022
($ in millions)Par Value of DebtNumber of Interest Rate Swaps HeldTotal Swap Notional Amount
2.40% notes due 2022
$1,000 4 $1,000 
Amounts Recorded on Balance Sheet Related to Fair Value Hedges
The table below presents the location of amounts recorded on the Condensed Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges:
Carrying Amount of Hedged LiabilitiesCumulative Amount of Fair Value Hedging Adjustment Increase (Decrease) Included in the Carrying Amount
($ in millions)March 31, 2022December 31, 2021March 31, 2022December 31, 2021
Balance Sheet Line Item in which Hedged Item is Included
Loans payable and current portion of long-term debt$1,003 $2,263 $4 $13 
Fair Value of Derivatives on a Gross Basis Segregated between those Derivatives that are Designated as Hedging Instruments and those that are Not Designated as Hedging Instruments
Presented in the table below is the fair value of derivatives on a gross basis segregated between those derivatives that are designated as hedging instruments and those that are not designated as hedging instruments:
  March 31, 2022December 31, 2021
  Fair Value of DerivativeU.S. Dollar
Notional		Fair Value of DerivativeU.S. Dollar
Notional
($ in millions)AssetLiabilityAssetLiability
Derivatives Designated as Hedging Instruments
Balance Sheet Caption
Interest rate swap contractsOther current assets$4 $— $1,000 $14 $— $2,250 
Foreign exchange contractsOther current assets341 — 7,429 271 — 6,778 
Foreign exchange contractsOther Assets46 — 1,595 43 — 1,551 
Foreign exchange contractsAccrued and other current liabilities— 21 1,060 — 24 1,623 
Foreign exchange contractsOther Noncurrent Liabilities— 1 9 — 1 43 
  $391 $22 $11,093 $328 $25 $12,245 
Derivatives Not Designated as Hedging Instruments
Balance Sheet Caption      
Foreign exchange contractsOther current assets$288 $— $12,466 $221 $— $10,073 
Foreign exchange contractsAccrued and other current liabilities— 219 7,700 — 96 10,640 
  $288 $219 $20,166 $221 $96 $20,713 
  $679 $241 $31,259 $549 $121 $32,958 
Information on Derivative Positions Subject to Master Netting Arrangements as if they were Presented on a Net Basis The following table provides information on the Company’s derivative positions subject to these master netting arrangements as if they were presented on a net basis, allowing for the right of offset by counterparty and cash collateral exchanged per the master agreements and related credit support annexes:
 March 31, 2022December 31, 2021
($ in millions)AssetLiabilityAssetLiability
Gross amounts recognized in the condensed consolidated balance sheet$679 $241 $549 $121 
Gross amounts subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet
(191)(191)(110)(110)
Cash collateral received(220)— (164)— 
Net amounts$268 $50 $275 $11 
Location and Amount of Pretax Gains and Losses of Derivatives
The table below provides information regarding the location and amount of pretax gains and losses of derivatives designated in fair value or cash flow hedging relationships:
Three Months Ended March 31,
($ in millions)202220212022202120222021
Financial Statement Line Items in which Effects of Fair Value or Cash Flow
Hedges are Recorded
Sales
Other (income) expense, net (1)
Other comprehensive income (loss)
$15,901 $10,627 $708 $(455)$60 $12 
(Gain) loss on fair value hedging relationships
Interest rate swap contracts
Hedged items
— — (10)(11)— — 
Derivatives designated as hedging instruments
— — 4 1 — — 
Impact of cash flow hedging relationships
Foreign exchange contracts
Amount of gain recognized in OCI on derivatives
— — — — 148 180 
Increase (decrease) in Sales as a result of AOCL reclassifications
67 (112)— — (67)112 
Interest rate contracts
Amount of gain recognized in Other (income) expense, net on derivatives
— — (1)(1)— — 
Amount of loss recognized in OCI on derivatives
— — — — (1)(1)
(1) Interest expense is a component of Other (income) expense, net.
Income Statement Effects of Derivatives Not Designated as Hedging Instruments
The table below provides information regarding the income statement effects of derivatives not designated as hedging instruments:
Amount of Derivative Pretax (Gain) Loss Recognized in Income
Three Months Ended March 31,
($ in millions)20222021
Derivatives Not Designated as Hedging InstrumentsIncome Statement Caption
Foreign exchange contracts (1)
Other (income) expense, net$28 $50 
Foreign exchange contracts (2)
Sales(2)(4)
(1) These derivative contracts primarily mitigate changes in the value of remeasured foreign currency denominated monetary assets and liabilities attributable to changes in foreign currency exchange rates.
(2) These derivative contracts serve as economic hedges of forecasted transactions.
Information on Investments in Debt and Equity Securities
Information on investments in debt and equity securities is as follows:
 March 31, 2022December 31, 2021
 Amortized
Cost		Gross UnrealizedFair
Value		Amortized
Cost		Gross UnrealizedFair
Value
($ in millions)GainsLossesGainsLosses
Commercial paper$372 $— $— $372 $— $— $— $— 
U.S. government and agency securities75 — — 75 80 — — 80 
Corporate notes and bonds4 — — 4 4 — — 4 
Foreign government bonds3 — — 3 2 — — 2 
Total debt securities$454 $— $— $454 $86 $— $— $86 
Publicly traded equity securities (1)
1,397 1,647 
Total debt and publicly traded equity securities
$1,851 $1,733 
(1) Unrealized net losses of $225 million were recorded in Other (income) expense, net on equity securities still held at March 31, 2022 in the first quarter of 2022. Unrealized net losses recorded in Other (income) expense, net on equity securities still held at March 31, 2021 were $181 million in the first quarter of 2021.
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Financial assets and liabilities measured at fair value on a recurring basis are summarized below:
Fair Value Measurements UsingFair Value Measurements Using
 Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
($ in millions)March 31, 2022December 31, 2021
Assets
Investments
Commercial paper$— $372 $— $372 $— $— $— $— 
Foreign government bonds— 3 — 3 — 2 — 2 
Publicly traded equity securities313 — — 313 368 — — 368 
 313 375 — 688 368 2 — 370 
Other assets (1)
U.S. government and agency securities75 — — 75 80 — — 80 
Corporate notes and bonds4 — — 4 4 — — 4 
Publicly traded equity securities1,084 — — 1,084 1,279 — — 1,279 
1,163 — — 1,163 1,363 — — 1,363 
Derivative assets (2)
Forward exchange contracts— 433 — 433 — 351 — 351 
Purchased currency options— 242 — 242 — 184 — 184 
Interest rate swaps— 4 — 4 — 14 — 14 
 — 679 — 679 — 549 — 549 
Total assets$1,476 $1,054 $— $2,530 $1,731 $551 $— $2,282 
Liabilities
Other liabilities
Contingent consideration$— $— $572 $572 $— $— $777 $777 
Derivative liabilities (2)
Forward exchange contracts— 240 — 240 — 120 — 120 
Written currency options— 1 — 1 — 1 — 1 
— 241 — 241 — 121 — 121 
Total liabilities$— $241 $572 $813 $— $121 $777 $898 
(1) Investments included in other assets are restricted as to use, including for the payment of benefits under employee benefit plans.
(2)    The fair value determination of derivatives includes the impact of the credit risk of counterparties to the derivatives and the Company’s own credit risk, the effects of which were not significant.
Information About the Changes in Liabilities for Contingent Consideration
Summarized information about the changes in the fair value of liabilities for contingent consideration associated with business combinations is as follows:
($ in millions)20222021
Fair value January 1$777 $841 
Changes in estimated fair value (1)
(84)(13)
Payments(119)— 
Other(2)(12)
Fair value March 31 (2)(3)
$572 $816 
(1) Recorded in Cost of sales, Research and development expenses, and Other (income) expense, net. Includes cumulative translation adjustments.
(2) Balance at March 31, 2022 includes $149 million recorded as a current liability for amounts expected to be paid within the next 12 months.
(3) At March 31, 2022 and December 31, 2021, $439 million and $620 million, respectively, of the liabilities relate to the termination of the Sanofi Pasteur MSD joint venture in 2016. As part of the termination, Merck recorded a liability for contingent future royalty payments of 11.5% on net sales of all Merck products that were previously sold by the joint venture through December 31, 2024. The fair value of this liability is determined utilizing the estimated amount and timing of projected cash flows using a risk-adjusted discount rate of 8% to present value the cash flows.